These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12465091)

  • 1. Further case of paroxysmal exercise-induced dystonia and some insights into pathogenesis.
    Barnett MH; Jarman PR; Heales SJ; Bhatia KP
    Mov Disord; 2002 Nov; 17(6):1386-7. PubMed ID: 12465091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable phenotype of rapid-onset dystonia-parkinsonism.
    Brashear A; Farlow MR; Butler IJ; Kasarskis EJ; Dobyns WB
    Mov Disord; 1996 Mar; 11(2):151-6. PubMed ID: 8684384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism.
    Brashear A; Butler IJ; Hyland K; Farlow MR; Dobyns WB
    Ann Neurol; 1998 Apr; 43(4):521-6. PubMed ID: 9546335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive dystonia with marked diurnal fluctuation.
    Ouvrier RA
    Ann Neurol; 1978 Nov; 4(5):412-17. PubMed ID: 570014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infantile-onset paroxysmal dystonia: a diagnostic dilemma.
    Wilmshurst JM; Howman-Giles R; Antony J
    J Child Neurol; 2001 Mar; 16(3):222-5. PubMed ID: 11305692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic dsyfunction in Tourette syndrome.
    Singer HS; Butler IJ; Tune LE; Seifert WE; Coyle JT
    Ann Neurol; 1982 Oct; 12(4):361-6. PubMed ID: 6184010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pterin abnormalities in dystonia: a metabolic marker with therapeutic implications.
    LeWitt PA; Miller LP; Levine RA; Lovenberg W; Newman RP; Papavasiliou A; Rayes A; Eldridge R; Burns RS
    Adv Neurol; 1988; 50():193-201. PubMed ID: 2456675
    [No Abstract]   [Full Text] [Related]  

  • 8. Sepiapterin reductase deficiency an autosomal recessive DOPA-responsive dystonia.
    Abeling NG; Duran M; Bakker HD; Stroomer L; Thöny B; Blau N; Booij J; Poll-The BT
    Mol Genet Metab; 2006; 89(1-2):116-20. PubMed ID: 16650784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid homovanillic acid is correlated to psychotic features in neurological patients with delirium.
    Ramirez-Bermudez J; Ruiz-Chow A; Perez-Neri I; Soto-Hernandez JL; Flores-Hernandez R; Nente F; Montes S; Rios C
    Gen Hosp Psychiatry; 2008; 30(4):337-43. PubMed ID: 18585537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished ventricular fluid dopamine metabolites in adult-onset dystonia.
    Tabaddor K; Wolfson LI; Sharpless NS
    Neurology; 1978 Dec; 28(12):1254-8. PubMed ID: 569784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
    Stuerenburg HJ; Ganzer S; Müller-Thomsen T
    Neuro Endocrinol Lett; 2004 Dec; 25(6):435-7. PubMed ID: 15665806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study on catecholamine metabolites in CSF in a patient with progressive dystonia with marked diurnal fluctuation].
    Maekawa N; Hashimoto T; Sasaki M; Oishi T; Tsuji S
    Rinsho Shinkeigaku; 1988 Oct; 28(10):1206-8. PubMed ID: 2464453
    [No Abstract]   [Full Text] [Related]  

  • 13. Serotonergic and dopaminergic metabolites in cerebrospinal fluid of epileptics.
    Mohan A; Nag D; Misra RN; Gujrati VR; Shanker K; Doval DC; Saxena RC; Bhargava KP
    Pharmazie; 1982 Nov; 37(11):803. PubMed ID: 6187028
    [No Abstract]   [Full Text] [Related]  

  • 14. Diminished levels of ventricular fluid norepinephrine metabolite and somatostatin in childhood-onset dystonia.
    Wolfson LI; Sharpless NS; Thal LJ
    Adv Neurol; 1988; 50():177-81. PubMed ID: 2456674
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
    Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
    J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial paroxysmal dystonic choreoathetosis revisited.
    Schloesser DT; Ward TN; Williamson PD
    Mov Disord; 1996 May; 11(3):317-20. PubMed ID: 8723150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaine-related movement disorders.
    Cardoso FE; Jankovic J
    Mov Disord; 1993 Apr; 8(2):175-8. PubMed ID: 8474485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment with talipexole dihydrochloride on abnormal involuntary movement in humans.
    Nishikawa T; Yamada S; Tsuda A; Tanaka M; Koga I; Uchida Y
    Clin Neuropharmacol; 1990 Jun; 13(3):259-63. PubMed ID: 1694103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of CSF catecholamine and its metabolites in acute and convalescent period of encephalitis.
    Kalita J; Kumar S; Vijaykumar K; Palit G; Misra UK
    J Neurol Sci; 2007 Jan; 252(1):62-6. PubMed ID: 17134724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The monamine metabolites in the CSF of the patients with spinocerebellar degeneration and motor neuron disease (author's transl)].
    Yamamoto M
    Rinsho Shinkeigaku; 1980 Jul; 20(7):503-9. PubMed ID: 6161732
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.